On the public citation graph

Membrane Env liposomes for immunization with HIV spikes

https://doi.org/10.1101/2020.11.29.403204
0 signed · 70 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1006/jsbi.1997.3848openalex-snapshot
Bio-Beads: An Efficient Strategy for Two-Dimensional Crystallization of Membrane Proteins
inferredcites →https://doi.org/10.1016/j.bbamem.2004.04.011openalex-snapshot
Membrane proteins, lipids and detergents: not just a soap opera
inferredcites →https://doi.org/10.1016/j.cell.2020.01.010openalex-snapshot
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
inferredcites →https://doi.org/10.1016/j.celrep.2015.03.047openalex-snapshot
Cleavage-Independent HIV-1 Env Trimers Engineered as Soluble Native Spike Mimetics for Vaccine Design
inferredcites →https://doi.org/10.1016/j.celrep.2016.07.074openalex-snapshot
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies
inferredcites →https://doi.org/10.1016/j.celrep.2017.04.013openalex-snapshot
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
inferredcites →https://doi.org/10.1016/j.celrep.2017.09.024openalex-snapshot
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model
inferredcites →https://doi.org/10.1016/j.celrep.2017.12.028openalex-snapshot
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models
inferredcites →https://doi.org/10.1016/j.celrep.2020.107583openalex-snapshot
HIV-1 Envelope and MPER Antibody Structures in Lipid Assemblies
inferredcites →https://doi.org/10.1016/j.immuni.2018.06.017openalex-snapshot
DEER Spectroscopy Measurements Reveal Multiple Conformations of HIV-1 SOSIP Envelopes that Show Similarities with Envelopes on Native Virions
inferredcites →https://doi.org/10.1016/j.immuni.2019.02.008openalex-snapshot
Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual
inferredcites →https://doi.org/10.1016/j.immuni.2019.06.004openalex-snapshot
Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan
inferredcites →https://doi.org/10.1016/j.immuni.2019.10.008openalex-snapshot
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability
inferredcites →https://doi.org/10.1016/j.virol.2007.04.033openalex-snapshot
A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120
inferredcites →https://doi.org/10.1016/s0006-3495(98)74015-9openalex-snapshot
A New “Gel-like” Phase in Dodecyl Maltoside–Lipid Mixtures: Implications in Solubilization and Reconstitution Studies
inferredcites →https://doi.org/10.1038/nature12053openalex-snapshot
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
inferredcites →https://doi.org/10.1038/ncomms10618openalex-snapshot
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
inferredcites →https://doi.org/10.1038/ncomms12040openalex-snapshot
Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability
inferredcites →https://doi.org/10.1038/nprot.2007.519openalex-snapshot
Membrane reconstitution of ABC transporters and assays of translocator function
inferredcites →https://doi.org/10.1038/nrd.2017.243openalex-snapshot
mRNA vaccines — a new era in vaccinology
inferredcites →https://doi.org/10.1038/s41467-017-01336-3openalex-snapshot
Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations
inferredcites →https://doi.org/10.1038/s41467-019-09678-wopenalex-snapshot
Spy&Go purification of SpyTag-proteins using pseudo-SpyCatcher to access an oligomerization toolbox
inferredcites →https://doi.org/10.1038/s41467-019-12973-1openalex-snapshot
An MPER antibody neutralizes HIV-1 using germline features shared among donors
inferredcites →https://doi.org/10.1038/s41586-019-1101-yopenalex-snapshot
Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET
inferredcites →https://doi.org/10.1038/s41590-018-0305-xopenalex-snapshot
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
inferredcites →https://doi.org/10.1038/s41591-018-0042-6openalex-snapshot
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
inferredcites →https://doi.org/10.1056/nejmoa0908492openalex-snapshot
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
inferredcites →https://doi.org/10.1073/pnas.1314351110openalex-snapshot
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation
inferredcites →https://doi.org/10.1073/pnas.1409954111openalex-snapshot
Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains
inferredcites →https://doi.org/10.1086/654816openalex-snapshot
Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV‐1 gp120 Vaccine
inferredcites →https://doi.org/10.1093/infdis/173.2.340openalex-snapshot
Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1
inferredcites →https://doi.org/10.1093/infdis/jiq175openalex-snapshot
A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent Neutralizing Antibodies but Limited Breadth of Neutralization in Human Volunteers
inferredcites →https://doi.org/10.1111/imr.12514openalex-snapshot
Complex immune correlates of protection in HIV ‐1 vaccine efficacy trials
inferredcites →https://doi.org/10.1111/tan.13759openalex-snapshot
Can we use structural knowledge to design a protective vaccine against HIV‐1?
inferredcites →https://doi.org/10.1126/science.1178746openalex-snapshot
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
inferredcites →https://doi.org/10.1126/science.1245625openalex-snapshot
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
inferredcites →https://doi.org/10.1126/science.aac4223openalex-snapshot
HIV-1 neutralizing antibodies induced by native-like envelope trimers
inferredcites →https://doi.org/10.1126/science.aad2450openalex-snapshot
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer
inferredcites →https://doi.org/10.1126/scitranslmed.aaz2686openalex-snapshot
Multiple roles for HIV broadly neutralizing antibodies
inferredcites →https://doi.org/10.1128/jvi.00198-11openalex-snapshot
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4 + T Cell Decline and High Viral Load during Acute Infection
inferredcites →https://doi.org/10.1128/jvi.00381-18openalex-snapshot
Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro
inferredcites →https://doi.org/10.1128/jvi.00415-17openalex-snapshot
Dense Array of Spikes on HIV-1 Virion Particles
inferredcites →https://doi.org/10.1128/jvi.00443-17openalex-snapshot
Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses
inferredcites →https://doi.org/10.1128/jvi.01216-17openalex-snapshot
Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex
inferredcites →https://doi.org/10.1128/jvi.01653-15openalex-snapshot
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity
inferredcites →https://doi.org/10.1128/jvi.01768-15openalex-snapshot
Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers
inferredcites →https://doi.org/10.1128/jvi.02321-15openalex-snapshot
Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites
inferredcites →https://doi.org/10.1128/jvi.02363-09openalex-snapshot
In-Solution Virus Capture Assay Helps Deconstruct Heterogeneous Antibody Recognition of Human Immunodeficiency Virus Type 1
inferredcites →https://doi.org/10.1128/jvi.02588-06openalex-snapshot
An Affinity-Enhanced Neutralizing Antibody against the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 gp41 Recognizes an Epitope between Those of 2F5 and 4E10
inferredcites →https://doi.org/10.1128/jvi.02652-15openalex-snapshot
Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers
inferredcites →https://doi.org/10.1128/jvi.03738-14openalex-snapshot
Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes
inferredcites →https://doi.org/10.1128/jvi.75.3.1165-1171.2001openalex-snapshot
Improved Elicitation of Neutralizing Antibodies against Primary Human Immunodeficiency Viruses by Soluble Stabilized Envelope Glycoprotein Trimers
inferredcites →https://doi.org/10.1128/jvi.76.17.8875-8889.2002openalex-snapshot
Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1
inferredcites →https://doi.org/10.1128/jvi.79.11.6577-6587.2005openalex-snapshot
Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped Viruses
inferredcites →https://doi.org/10.1128/jvi.79.16.10210-10217.2005openalex-snapshot
Formaldehyde-Treated, Heat-Inactivated Virions with Increased Human Immunodeficiency Virus Type 1 Env Can Be Used To Induce High-Titer Neutralizing Antibody Responses
inferredcites →https://doi.org/10.1128/mbio.00036-17openalex-snapshot
Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers
inferredcites →https://doi.org/10.1371/journal.pone.0021339openalex-snapshot
Functional Stability of Unliganded Envelope Glycoprotein Spikes among Isolates of Human Immunodeficiency Virus Type 1 (HIV-1)
inferredcites →https://doi.org/10.1371/journal.pone.0065220openalex-snapshot
Detailed Topology Mapping Reveals Substantial Exposure of the “Cytoplasmic” C-Terminal Tail (CTT) Sequences in HIV-1 Env Proteins at the Cell Surface
inferredcites →https://doi.org/10.1371/journal.pone.0170672openalex-snapshot
Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs
inferredcites →https://doi.org/10.1371/journal.ppat.1003184openalex-snapshot
Increased Functional Stability and Homogeneity of Viral Envelope Spikes through Directed Evolution
inferredcites →https://doi.org/10.1371/journal.ppat.1003618openalex-snapshot
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
inferredcites →https://doi.org/10.1371/journal.ppat.1004932openalex-snapshot
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site
inferredcites →https://doi.org/10.1371/journal.ppat.1006986openalex-snapshot
Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins
inferredcites →https://doi.org/10.1586/14760584.6.5.711openalex-snapshot
Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations
inferredcites →https://doi.org/10.2174/138161206776055859openalex-snapshot
Current Progress in the Development of HIV Vaccines
inferredcites →https://doi.org/10.3389/fimmu.2017.01654openalex-snapshot
Glutaraldehyde Cross-linking of HIV-1 Env Trimers Skews the Antibody Subclass Response in Mice
inferredcites →https://doi.org/10.3389/fimmu.2020.583077openalex-snapshot
Emerging Concepts and Technologies in Vaccine Development
inferredcites →https://doi.org/10.3390/v12010074openalex-snapshot
Factors That Govern the Induction of Long-Lived Antibody Responses
inferredcites →https://doi.org/10.4049/jimmunol.1300971openalex-snapshot
Induction of HIV-1 Broad Neutralizing Antibodies in 2F5 Knock-in Mice: Selection against Membrane Proximal External Region–Associated Autoreactivity Limits T-Dependent Responses
inferredcites →https://doi.org/10.4049/jimmunol.1500527openalex-snapshot
Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.